Recurrent extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infection due to an infected intrauterine device.
10.11622/smedj.2013213
- Author:
Chee-Kin HUI
- Publication Type:Case Reports
- MeSH:
Adult;
Anti-Bacterial Agents;
therapeutic use;
Escherichia coli Infections;
drug therapy;
etiology;
Female;
Humans;
Intrauterine Devices;
adverse effects;
Microbial Sensitivity Tests;
Recurrence;
Treatment Outcome;
Urinary Tract Infections;
drug therapy;
etiology;
microbiology;
Uropathogenic Escherichia coli;
enzymology;
beta-Lactamases;
metabolism
- From:Singapore medical journal
2014;55(2):e28-30
- CountrySingapore
- Language:English
-
Abstract:
The use of intrauterine devices (IUDs) have been widespread since the 1960s. In 2002, the World Health Organization estimated that approximately 160 million women worldwide use IUDs. However, IUDs are associated with short-term complications such as vaginal bleeding, pelvic discomfort, dyspareunia and pelvic infection. Herein, we report the case of a woman who had recurrent urinary tract infection (UTI) due to the use of an IUD, even after treatment. The patient developed four episodes of UTI within a seven-month period after IUD insertion. During each episode of UTI, extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E. coli) was cultured from the patient’s midstream urine. The IUD was finally removed, and culture of the removed IUD was positive for ESBL-producing E. coli. An infected IUD as a source of recurrent UTI should be considered in women with IUD in situ who develop recurrent UTI even after treatment.
